Followers

Monday, 6 November 2017

Five things for pharma marketers to know: Friday, November 3, 2017

Experimental Gilead and GSK HIV drugs are expected to compete; GSK R&D head resigns; Valeant subsidiary scores eye-drug approval

from Most popular articles from Medical Marketing and Media http://ift.tt/2hJsDB5
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)